Coronary Artery Bypass Graft Devices | Medtech 360 | Market Analysis | US | 2018
The mature US CABG device market will contract slightly through 2026 as procedure volumes decline due to increasing use of PCI for the treatment of CAD; however, rising interest in off-pump and minimally invasive approaches to CABG surgery will help to mitigate overall revenue declines to some extent.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for CABG devices in the US, with market projections across a 10-year period.